Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001390478-16-000126

Options or other derivatives

  • Director acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
GALLIKER STEPHEN S Director 2016-07-14 Grant or award · Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/primary_doc.xml…